1 value stock yielding 6.9% I’d buy and hold for 10 years!

This Fool explains why she’s bullish on this value stock with its enticing passive income opportunity, as well as future growth prospects.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Diverse group of friends cheering sport at bar together

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

One value stock I’ll be buying for my holdings as soon as I can is Target Healthcare REIT (LSE: THRL). Here’s why!

Income yielding property

Target is set up as a real estate investment trust (REIT). It owns and operates property assets and makes rental income. The allure of REITs is that they must return 90% of profits to shareholders. As a passive income seeker, this is a dream!

Target specialises in care home properties and currently owns and operates close to 100 around the UK.

Over a 12-month period, the shares are down 4% from 84p at this time last year, to current levels of 80p. The share price chart below looks like the journey of an exciting roller coaster in a theme park. However, recent economic turbulence hasn’t helped property stocks, hence the up and down nature of its shares.

The positives and negatives

From a bullish perspective, the passive income opportunity at present looks too good to miss out on. A dividend yield of 6.9% is higher than the FTSE 100 average yield of 3.8%. However, I’m conscious that dividends are never guaranteed.

Next, the shares look good value for money on a price-to-earnings ratio of 12. I reckon recent volatility has held the shares back. There’s a good chance once volatility dissipates, they could climb, making them potentially more expensive later down the line.

Moving on, I also think Target is primed for growth in the future, hence my long-term buy and hold outlook at such an enticing valuation at present. Care homes should continue to experience robust demand due to the UK population growing and more crucially, ageing. Demand for care services rising could help boost Target’s performance, and investor returns.

Finally, a recent positive update released on 1 February made for good reading. The business confirmed the net asset value (NAV) of its properties had increased. Furthermore, cash levels looked in a good position supporting a healthy balance sheet, which bodes well for returns and growth.

From a risk perspective, many REITs and property firms must borrow money for growth purposes such as buying new properties. At present, higher interest rates make any borrowing more costlier, which could hurt performance and payouts moving forward.

The bigger risk I’m concerned about is the current healthcare staff shortage in the UK. Reports recently have noted many are leaving the profession due to pay issues or an imbalanced work life balance. Others are seeking opportunities abroad, where the pay and balance is more attractive. Target may be able to grow its estate but if it doesn’t have the staff to operate them, problems could arise.

My verdict

There’s a lot to like about Target, hence my overall bullishness around the stock. An enticing passive income opportunity, attractive valuation, coupled with the current demographic of the population, could help the shares climb nicely in the future.

Like with all stocks, there are risks to consider. However, I reckon the rewards outweigh the risks which is why I’d buy and hold Target shares for a long time for returns and growth.

Sumayya Mansoor has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young Caucasian woman with pink her studying from her laptop screen
Investing Articles

New to investing? Here’s Warren Buffett’s strategy for starting from scratch

Warren Buffett says he could find opportunities to earn a 50% annual return in the stock market if he was…

Read more »

Investing Articles

Can the sensational Barclays share price do it all over again in 2026?

Harvey Jones is blown away by what the Barclays share price has been doing lately. Now he looks at whether…

Read more »

Investing Articles

Prediction: in 2026 mega-cheap Diageo shares could turn £10,000 into…

Diageo shares have been burning wealth lately but Harvey Jones says long-suffering investors in the FTSE 100 stock may get…

Read more »

Investing Articles

This overlooked FTSE 100 share massively outperformed Tesla over 5 years!

Tesla has been a great long-term investment, but this lesser-known FTSE 100 company would have been an even better one.

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

I’m backing these 3 value stocks to the hilt – will they rocket in 2026?

Harvey Jones has bought these three FTSE 100 value stocks on three occasions lately, averaging down every time they fall.…

Read more »

Investing Articles

Can the barnstorming Tesco share price do it all over again in 2026?

Harvey Jones is blown away by just how well the Tesco share price has done lately, and asks whether the…

Read more »

Investing Articles

Up 45% in a year with a 7.2% yield and a P/E of 13! Is it too late to buy this fabulous FTSE 250 stock?

Harvey Jones spotted the potential in this ultra-high-yielding FTSE 250 recovery stock, and is thrilled to see it starting to…

Read more »

Investing Articles

What on earth’s going to happen to the BP share price in 2026?

Harvey Jones looks at how the BP share price is shaping up for the year ahead, and finds investors have…

Read more »